UP-Pharma has been providing pharmacokinetics and drug metabolism service under GLP standards since 2006 and has recently taken this expertise forward to the biopharmaceutical market and established reputable and reliable outsourcing solutions. Our new facility in Beijing has been operational for since 2006 and has been inspected by SFDA. We can support early development pre-clinical work through phase IV studies. We have recently doubled our analytical capacity and are capable of fast turnaround analysis whilst maintaining excellent quality standards.
the link:

